Catheter Precision, Inc. VTAK 深 沪
等待开盘 04-02 09:30:00 美东时间
0.94
-0.070
-6.93%
华盛通- 最 高1.055
- 今 开1.02
- 成交量 12.09万股
- 最 低 0.93
- 昨 收 1.01
- 总市值 221.57万
- 52周最高 15.6807
- 市盈率 静 --
- 换手率 5.13%
- 52周最低 0.93
- 委 比 1.79%
- 总股本 235.71万
- 历史最高 5225000.00
- 量 比 1.40
- 振 幅 12.38%
- 历史最低 0.93
- 每 手 1
- 风险率 1.62%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Catheter Precision Q4 EPS $(2.88) Up From $(21.66) YoY, Sales $238.000K Up From $149.000K YoY
Catheter Precision (AMEX:VTAK) reported quarterly losses of $(2.88) per share. This is a 86.7 percent increase over losses of $(21.66) per share from the same period last year. The company reported $238.000 thousand in
04-01 05:50
Catheter Precision Acquires Remaining 80% Equity In Fly Flyte From Creatd; Financial Terms Undisclosed
Catheter Precision, Inc. (NYSE American: VTAK) today announced that it has completed the acquisition of the remaining 80.02% equity interest in Fly Flyte, Inc. ("Flyte") from Creatd, Inc. (OTCQB:CRTDD), resulting in 100%
03-10 20:06
Catheter Precision Divests Non-Core Assets As It Shifts Focus
Catheter Precision sells atherectomy catheter tech to sharpen focus on electrophysiology growth.
02-19 23:21
Catheter Precision Acquire 19.98% Equity In Aviation Operator Flyte; Financial Terms Not Disclosed
Catheter Precision, Inc. (NYSE:VTAK) today announced a strategic minority investment in Fly Flyte, Inc. ("Flyte"), an FAA-certified regional aviation operator utilizing AI-enabled operations and a growing fleet of Cirrus
02-17 20:47
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers CytoMed Therapeutics (NASDAQ:GDTC) shares moved upwards by 6.9% to $1....
02-14 05:06
Catheter Precision Announces Increase In Hospital Evaluations, Approvals For Its LockeT Suture Retention Device
Catheter Precision, Inc. (NYSE American: VTAK), a medical device company specializing in advanced electrophysiology solutions, today announced a surge in hospital evaluations and approvals for its LockeT suture retention
02-04 21:11
Catheter Precision Launches LockeT Suture Retention Device In Switzerland
Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market today announced the successful launch of
2025-12-01 21:02
Catheter Precision, Inc. Common Stock Q3 EPS $(1.70) Misses $(0.11) Estimate, Sales $226.000K Miss $1.700M Estimate
Catheter Precision, Inc. Common Stock (AMEX:VTAK) reported quarterly losses of $(1.70) per share which missed the analyst consensus estimate of $(0.11) by 1445.45 percent. This is a 95.55 percent increase over losses of
2025-11-14 05:40
Catheter Precision Enters Distribution Agreement with FuMedica AG to Bring LockeT to Switzerland
Catheter Precision, Inc., a US-based medical device company, has signed a strategic distribution agreement with FuMedica AG, a leading Swiss distributor, to introduce its LockeT suture retention device to hospitals and clinics across Switzerland. LockeT is a Class 1 FDA-registered and CE-approved device designed to simplify vascular access site closure following cardiac procedures. FuMedica AG, renowned for its expertise in distributing advanced ...
2025-10-16 12:00
Catheter Precision Increases Authorized Shares to 500 Million
An announcement from Catheter Precision ( ($VTAK) ) is now available. On Octobe...
2025-10-16 04:54
